GTCR完成对欧洲领先仿制药公司Zentiva的收购-动脉网

GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company

PR Newswire 等信源发布 2026-04-09 15:00



可切换为仅中文







GTCR to support Zentiva's next phase of growth, building on its strong foundation of quality, scale and market leadership

GTCR 将支持 Zentiva 的下一阶段增长，基于其强大的质量、规模和市场领导地位基础

CHICAGO and PRAGUE

芝加哥和布拉格

，

April 9, 2026

2026年4月9日

/PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has closed the previously announced acquisition of Zentiva (the 'Company'), a leading European generics pharmaceutical company, from Advent, a leading global private equity investor.

/PRNewswire/ -- 领先的私募股权公司GTCR今日宣布，已完成此前宣布的从全球领先的私募股权投资者Advent手中收购欧洲领先的仿制药公司Zentiva（“公司”）的交易。

Zentiva is focused on the development, manufacturing and supply of generic, branded specialty and over-the-counter medicines and products, serving more than 100 million people across over 40 countries. The Company is supported by established R&D capabilities and a deep commitment to clinical excellence and product quality across its portfolio..

Zentiva专注于仿制药、品牌专科药和非处方药及产品的开发、生产和供应，为40多个国家的超过1亿人提供服务。公司依托成熟的研发能力和对临床卓越性及产品组合质量的深厚承诺。

GTCR will partner with Zentiva's management team, led by Chief Executive Officer Steffen Saltofte and Executive Chairperson Kieran Murphy, to support the Company's next phase of growth. GTCR has longstanding relationships with both Mr. Saltofte and Mr. Murphy, both seasoned leaders with proven track records at various healthcare businesses, including at Acino and GE HealthCare..

GTCR将与由首席执行官Steffen Saltofte和执行主席Kieran Murphy领导的Zentiva管理团队合作，支持公司下一阶段的增长。GTCR与Saltofte先生和Murphy先生都有着长期的合作关系，他们都是在包括Acino和GE HealthCare等多家医疗保健企业中拥有卓越业绩的资深领导者。

GTCR has a long history of investing in healthcare over the past 45 years, including in the pharmaceutical sector. The firm will support Zentiva's next phase of growth through continued investment in new product development, portfolio breadth, and geographic reach, with a focus on improving patient access to essential medicines and supporting sustainable healthcare systems..

GTCR 在过去的 45 年间在医疗保健领域有着悠久的投资历史，其中包括制药行业。该机构将通过持续投资新产品开发、拓展产品组合广度和地理覆盖范围，支持 Zentiva 的下一阶段增长，重点关注改善患者获取基本药物的途径，并支持可持续的医疗保健体系。

'We are proud of Zentiva's strong history and footprint. We look forward to partnering with GTCR at an important inflection point following several years of growth,' said Steffen Saltofte, CEO of Zentiva. 'With GTCR's support and significant industry expertise, we believe we are ideally placed to accelerate our momentum and continue our mission of expanding access to high-quality, affordable medicines to millions of people across Europe.'.

“我们为Zentiva强大的历史和影响力感到自豪。在经历了数年的增长之后，我们期待在这一重要的转折点与GTCR合作，”Zentiva首席执行官Steffen Saltofte表示。“在GTCR的支持和其显著的行业专业经验下，我们相信我们有能力加速发展势头，并继续推进我们的使命，即为欧洲数百万民众提供高质量且价格合理的药品。”

'We are excited to partner with Steffen and the Zentiva team to further the Company's success,' said Sean Cunningham, Managing Director and Head of Healthcare at GTCR. 'As policymakers increasingly prioritize expanding access to essential medicines while ensuring long-term sustainability of healthcare systems, Zentiva plays a critical role in delivering high-quality, cost-effective therapies at scale.

“我们很高兴与施特芬以及Zentiva团队合作，进一步推动公司的成功，”GTCR董事总经理兼医疗保健主管肖恩·坎宁安表示。“随着政策制定者日益重视扩大基本药物的获取渠道，同时确保医疗系统的长期可持续性，Zentiva在大规模提供高质量、高性价比的治疗方案方面发挥着关键作用。”

Combined with its differentiated geographic footprint and low-cost manufacturing capabilities, Zentiva is well positioned to strengthen its competitive advantage and deliver long-term growth and impact.'.

结合其差异化的地理足迹和低成本制造能力，Zentiva 有望巩固其竞争优势，实现长期增长和影响力。

Tom Allen, Managing Director at Advent, added

汤姆·艾伦，Advent董事总经理补充道

，

'We are immensely proud of the business Zentiva has become during our partnership — a scaled, growing European generics platform, with a strong competitive footprint, a commitment to quality, and a clear mission to expand access to affordable medicines. We would like to thank Steffen and all the talented Zentiva team members who played a part in the company's transformation.

“在我们的合作期间，Zentiva 发展成为一家令我们无比自豪的企业——一个规模不断扩大、在欧洲增长的仿制药平台，拥有强大的竞争力、对质量的坚定承诺以及扩大平价药品获取渠道的明确使命。我们要感谢 Steffen 和所有参与公司转型的才华横溢的 Zentiva 团队成员。”

We look forward to watching Zentiva go from strength to strength in the years ahead.'.

我们期待着Zentiva在未来几年中不断壮大。

GTCR was advised by Barclays Bank PLC, acting through its Investment Bank, and BNP Paribas as lead financial advisors, Morgan Stanley & Co. LLC as a financial advisor, and Kirkland & Ellis LLP as legal advisor.

GTCR 得到了巴克莱银行 PLC（通过其投资银行）、法国巴黎银行作为主要财务顾问、摩根士丹利有限责任公司作为财务顾问以及柯克兰－埃利斯律师事务所作为法律顾问的建议。

Advent was advised by Goldman Sachs and PJT Partners as lead financial advisors and Freshfields as lead legal advisor.

高盛和PJT Partners担任主要财务顾问，富而德律师事务所担任主要法律顾问。

About GTCR

关于GTCR

Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors.

成立于1980年的GTCR是一家领先的私募股权公司，专注于《领导者战略™》——在核心领域寻找并与管理领导者合作，通过自然增长和战略性收购来识别、获取并打造市场领先的企业。GTCR专注于投资商业与消费者服务、金融服务与技术、医疗保健以及技术、媒体和电信行业的变革性增长企业。

Since its inception, GTCR has invested more than $30 billion in approximately 300 companies, and the firm currently manages approximately $50 billion in equity capital. GTCR is based in Chicago with offices in New York and West Palm Beach. For more information, please visit .

自成立以来，GTCR已向约300家公司投资超过300亿美元，目前该机构管理着约500亿美元的股权资本。GTCR总部位于芝加哥，在纽约和西棕榈滩设有办事处。欲了解更多信息，请访问。

www.gtcr.com

. Follow us on

关注我们

领英

。

About Zentiva

关于Zentiva

Zentiva provides health and wellbeing for all generations, with focus on developing, producing, and delivering high-quality, affordable medicines to more than 100 million people in over 40 countries across Europe and beyond. Zentiva has four manufacturing sites and a broad network of external manufacturing partners to ensure supply security.

Zentiva为各代人提供健康与福祉，专注于开发、生产和交付高质量且价格合理的药品，覆盖欧洲及其他地区40多个国家的逾1亿人口。Zentiva拥有四个生产基地和广泛的外部制造合作伙伴网络，以确保供应安全。

Zentiva employs more than 5,400 unique talents, bonded together by a commitment to the people who depend on our products every day. Visit us at .

Zentiva 拥有超过 5,400 名独特的员工，他们因对依赖我们产品的用户做出的承诺而团结在一起。访问我们：。

www.zentiva.com

About Advent

关于Advent

Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $100 billion in assets under management* and have made 448 investments across 44 countries..

安宏资本是全球领先的私募股权投资者，致力于与管理团队、企业家和创始人合作，帮助企业实现转型。安宏资本在全球五大洲设有16个办公室，管理资产超过1000亿美元*，并在44个国家完成了448项投资。

Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans.

自1984年成立以来，我们已在五个核心领域——商业与金融服务、消费品、医疗保健、工业和科技——发展出专业的市场专长。这种方法得益于我们对细分领域的深刻理解，这些知识贯穿于我们投资策略的每个方面，从寻找机会到与管理层合作执行价值创造计划。

We bring hands-on operational expertise to enhance and accelerate businesses..

我们带来实际操作的专业知识，以增强和加速企业发展。

As one of the largest privately-owned partnerships, our 655 colleagues leverage the full ecosystem of Advent's global resources, including our Portfolio Support Group, insights provided by industry expert Operating Partners and Operations Advisors, as well as bespoke tools to support and guide our portfolio companies as they seek to achieve their strategic goals..

作为最大的私人合伙企业之一，我们的655名同事充分利用了Advent全球资源的完整生态系统，包括我们的投资组合支持小组、行业专家运营合伙人和运营顾问提供的见解，以及定制工具，以支持和指导我们的投资组合公司实现其战略目标。

To learn more, visit our

要了解更多信息，请访问我们的网站

website

网站

or connect with us on

或通过以下方式联系我们

领英

。

*Assets under management (AUM) as of September 30, 2025. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles.

截至2025年9月30日的资产管理规模（AUM）。AUM包括归属于Advent咨询客户的资产，以及员工和第三方共同投资工具的资产。

Media Contacts

媒体联系人

GTCR Media Contact

GTCR媒体联系人

Josh Clarkson / Ryan Smith / Peter Gavaris

乔什·克拉克森 / 瑞恩·史密斯 / 彼得·加瓦里斯

[email protected]

电子邮件地址

Zentiva Media Contact

Zentiva媒体联系人

Marie-Claire Rees